Global Primary Progressive MS Treatment Market to Reach US$3.01 Billion by 2030, Driven by New Drug Approvals and Rising Diagnosis Rates
Primary Progressive Multiple Sclerosis (PPMS) is a kind of MS that affects around 15% of all MS patients. PPMS, unlike other types of MS, is …